The Psychedelic Medicine Market is segmented by application, with depression and PTSD holding the largest shares. Depression, particularly treatment-resistant depression, is a major focus of psychedelic research. Psilocybin and ketamine have both shown remarkable efficacy in rapidly reducing depressive symptoms, even in patients who have not responded to other...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek